Skip to main content

Closed

TRDA: Entrada Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-3109.3%

ROIC-55.6%

Financially safe

Stretched

Debt / equity0.18×

Interest coverage0.0×

Current ratio13.90×

Entrada Therapeutics, Inc.

TRDANASDAQ Global Market·USD·Closed

Entrada Therapeutics, Inc.

TRDANASDAQ·USD·Closed

$6.79

+0.30%

$6.79

+$0.02 (0.30%)

52W Range

16thpctl

Volume

0.73×avg

Mkt Cap

263.59MUSD

P/E

-1.7TTM

Div Yield

–ann

52W Range

16thpctl

Volume

0.73×avg

Market Cap

263.59MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings